Infinium Pharmachem Ltd.

NSE: INFINIUM

₹261.70

up-down-arrow-1.30 (-0.49%)

As on 01-Sep-2026IST

Market cap

info icon

₹408 Cr

Revenue (TTM)

info icon

₹156 Cr

P/E Ratio

info icon

33.6

P/B Ratio

info icon

3.7

Div. Yield

info icon

0 %

Infinium Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 252.00 High: 270.50

52 Week Range

Low: 189.40 High: 282.90

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹8 Cr

  • ROEROE information

    9.3 %

  • ROCEROCE information

    13.2 %

  • Industry P/EIndustry P/E information

    39.7

  • EV/EBITDAEV/EBITDA information

    17.9

  • Debt to EquityDebt to Equity information

    0.5

  • Book ValueBook Value information

    ₹70.2

  • EPSEPS information

    ₹5.2

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    15,583,120

6 Years Aggregate

CFO

₹6.50 Cr

EBITDA

₹68.52 Cr

Net Profit

₹39.45 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Infinium
17.4 25.5 22.4 3.6 -0.4 -- --
BSE Healthcare
18.1 1.0 9.6 17.6 22.5 14.1 12.2
As on 01-Sep-2026
Company
2025
2024
Infinium
-27.4 30.8
BSE Small Cap
-6.6 29.0
BSE Healthcare
-3.3 43.1

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Infinium
261.7 407.8 155.7 7.8 -- 9.3 33.6 3.7
3,174.3 25,979.8 1,461.8 387.4 34.5 25.2 67.3 15.1
843.9 16,595.8 7,784.0 688.5 10.6 14 23.9 2.8
460.0 17,589.9 2,141.5 58.5 5.8 3.3 165.6 4.6
837.2 20,755.5 5,632.3 662.4 17.2 14.3 31.3 4.2
1,527.9 17,502.0 1,543.3 -48.6 3.6 -0.6 -- 3.0
213.2 28,384.3 9,205.3 -371.8 1.7 -3.8 -- 3.5
1,822.2 30,127.6 1,935.8 288.2 20.6 29.8 104.5 22.4
402.1 16,213.4 3,600.2 221.0 9.7 5.6 73.4 3.4
1,850.6 30,074.9 3,564.0 414.0 15.3 8.4 73.5 6.0

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Infinium

Manufacture of pharmaceuticals, medicinal chemical and botanical products

  • Incorporated

    2003

  • Chairman

    --

  • Managing Director

    Sanjay Kumar Patel

  • Headquarters

    Anand Dist, Gujarat

  • Website

    www.infiniumpharmachem.com

FAQs for Infinium

The share price of Infinium Pharmachem Ltd is ₹261.70 (NSE) as of 01-Sep-2026 IST. Infinium Pharmachem Ltd has given a return of -0.41% in the last 3 years.

The P/E ratio of Infinium Pharmachem Ltd is 33.56 times as on 01-Sep-2026, a 15 discount to its peers’ median range of 39.70 times.
The P/B ratio of Infinium Pharmachem Ltd is 3.73 times as on 01-Sep-2026, a 0 premium to its peers’ median range of 3.72 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
46.28
3.44
2024
28.20
5.42
2023
0.00
0.00
2022
0.00
0.00
2021
0.00
0.00

The 52-week high and low of Infinium Pharmachem Ltd are Rs 282.90 and Rs 189.40 as of 01-Sep-2026.

Infinium Pharmachem Ltd has a market capitalisation of ₹ 408 Cr as on 01-Sep-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Infinium Pharmachem Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...
loading...